This Investment Digest is an update for it's previous iteration. It summarizes key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI).

​

Here we have presented the information about key industry trends, 470 promising AI-in-Pharma startups, and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.